The Business Research Company’s 2026 market reports are designed to deliver research that is more actionable and strategically valuable. Key offerings include market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights.
Bioinformatics Platform Market Size Insights: Annual Growth Rate, Revenue Outlook And Forecast Drivers
The bioinformatics platform market has experienced robust expansion in recent years. This market is projected to expand from $10.44 billion in 2025 to $11.27 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.9%. Historically, this growth has been fueled by factors such as the rise in genomic sequencing projects, the broadening of life science research, the initial development of bioinformatics tools, collaborative academic research, and the escalating complexity of biological data.
The bioinformatics platform market is projected to experience substantial expansion in the coming years, reaching a valuation of $15.19 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.8%. This anticipated growth during the forecast period is primarily driven by factors such as the increasing adoption of precision medicine, the integration of artificial intelligence (AI) into bioinformatics, the expansion of pharmaceutical research and development (R&D), the greater use of cloud computing in research, and the rising need for accelerated drug discovery processes. Key trends expected over the forecast period encompass the development of cloud-based bioinformatics platforms, AI-powered genomic analysis, integrated multi-omics data platforms, collaborative research data ecosystems, and automated bioinformatics workflows.
Request A Free Excerpt Of The Bioinformatics Platform Global Market Report 2026:
What Will Drive Bioinformatics Platform Market Growth Through 2030?
The expanding acceptance of personalized medicine is expected to drive the growth of the bioinformatics platform market in the coming years. Personalized medicine represents a healthcare approach that tailors treatment and prevention strategies based on an individual’s distinct genetic profile, lifestyle choices, and environmental factors. The escalating demand for personalized medicine is fueled by advancements in genomic technologies, which facilitate the precise identification of genetic variations linked to diseases, leading to more targeted and effective treatments. This growing demand for personalized medicine in turn necessitates advanced bioinformatics platforms, as they are crucial for analyzing and interpreting extensive genomic and clinical data to develop individualized treatment plans. For instance, in February 2024, the Personalized Medicine Coalition (PMC), a US-based non-profit organization, noted that the FDA authorized 16 new personalized therapies for patients with rare diseases in 2023, a significant increase from the six approvals granted in 2022. Therefore, the increasing adoption of personalized medicines will boost the growth of the bioinformatics platform market.
Bioinformatics Platform Market Segment Analysis Covering All Major Categories
The bioinformatics platform market covered in this report is segmented –
1) By Platform Type: Sequence Analysis Platforms, Sequence Alignment Platforms, Sequence Manipulation Platforms, Structural And Functional Analysis Platforms, Other Platforms
2) By Application: Genomics, Proteomics, Drug Discovery, Personalized Medicine, Other Applications
3) By End-User: Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Healthcare Providers, Other End Users
Subsegments:
1) By Sequence Analysis Platforms: Whole Genome Sequencing (WGS) Platforms, Targeted Sequencing Platforms, RNA Sequencing Platforms, Metagenomic Sequencing Platforms, Exome Sequencing Platforms
2) By Sequence Alignment Platforms: Global Alignment Tools, Local Alignment Tools, Pairwise Alignment Tools, Multiple Sequence Alignment Tools, Structural Alignment Tools
3) By Sequence Manipulation Platforms: Sequence Assembly Tools, Sequence Editing Tools, Sequence Visualization Tools, Sequence Conversion Tools
4) By Structural And Functional Analysis Platforms: Protein Structure Prediction Tools, Structural Bioinformatics Tools, Functional Annotation Tools, Molecular Docking Platforms, Pathway Analysis Tools
5) By Other Platforms: Data Integration Platforms, Data Visualization Platforms, Bioinformatics Workflow Management Platforms, Cloud-Based Bioinformatics Platforms
Major Trends Shaping The Future Of The Bioinformatics Platform Market
Leading companies operating in the bioinformatics platform market are developing advanced technological solutions, including multiomic data mapping platforms, to deliver accurate insights and improve the understanding of intricate diseases and conditions. These multiomic data mapping platforms are integrated systems designed to analyze and correlate data from multiple biological layers, such as genomics, transcriptomics, proteomics, and metabolomics, offering a comprehensive understanding of complex biological processes. For example, in February 2023, BioSkryb Genomics, a US-based biotechnology company, introduced the BaseJumper Bioinformatics Platform. This platform aims to enhance the ResolveOME system by simplifying large-scale single-cell informatics. It enables swift organization and mapping of multiomic data (DNA, RNA, and protein) generated by ResolveOME, thereby streamlining data interpretation. The platform also features dynamic filtering and an array of visualization tools, allowing researchers from various disciplines to readily analyze and visualize complex datasets.
Bioinformatics Platform Market Competitive Environment And Key Companies
Major companies operating in the bioinformatics platform market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Dassault Systèmes SE, Agilent Technologies Inc., Illumina Inc., Wuxi NextCODE, PerkinElmer Inc., Partek Incorporated, Qiagen N.V.,Genedata AG,DNAnexus Inc., Sophia Genetics S.A., Accelrys Inc., DNASTAR Inc., Gene Codes Corporation, BGI Group, Fios Genomics Ltd., Golden Helix Inc., Benchling Inc., Velsera Inc., Seqera Labs, Lifebit Biotech Ltd., Genestack Ltd., Biomatters Ltd., Schrödinger Inc., Chemical Computing Group Inc.
Access Expert Bioinformatics Platform Market Analysis In The Full Report:
Which Regions Are Covered In The Bioinformatics Platform Market Report?
North America was the largest region in the bioinformatics platform market in 2025. The regions covered in the bioinformatics platform market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.
